January 10, 2017

Weekly Biomedicine Newsletter

 thumbnail 

News

One man’s quest to hack his own genes

When Brian Hanley set out to test a gene therapy, he started with himself.

 
 thumbnail 

News

Are these seven Nobel Prize winners endorsing anti-aging nonsense?

Nobel Prize winners lend their faces, credibility, to supplement maker Elysium’s advertising campaign.

 
 thumbnail 

News

Spraying RNA on plants silences a gene and protects them from viruses

The technique could be faster and more versatile than developing genetically modified crops from scratch.

 
 

News

Cancer-fighting startup Grail is about to get a billion dollar boost

Grail, a company that aims to use a blood test to spot cancer, has announced a massive round of funding for its experimental approach.

 
 thumbnail 

News

An Ebola vaccine that appears to be 100 percent effective still won’t stop future cases

A vaccine against the deadly virus has passed a key testing milestone, but it’s not a long-term solution to stop it.

 
 

News

A genetically modified malaria vaccine has been proven safe in humans

Researchers have tested a modified malaria parasite in humans that has been shown to be safe and to trigger an immune response.

 
  See More Stories »  

If you would like to update the frequency or type of newsletters received, please edit your newsletter preferences or unsubscribe from all MIT Technology Review communications.

MIT Technology Review
One Main Street
Cambridge, MA 02142